<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Ayush 64 for Covid patients | Jugaadin News</title>
	<atom:link href="https://news.jugaadin.com/tag/ayush-64-for-covid-patients/feed/" rel="self" type="application/rss+xml" />
	<link>https://news.jugaadin.com</link>
	<description>Latest News </description>
	<lastBuildDate>Thu, 29 Apr 2021 09:19:38 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.1</generator>
<site xmlns="com-wordpress:feed-additions:1">167890018</site>	<item>
		<title>AYUSH 64 can be recommended for asymptomatic, mild to moderate COVID-19 patients: Ministry of Ayush</title>
		<link>https://news.jugaadin.com/ayush-64-can-be-recommended-for-asymptomatic-mild-to-moderate-covid-19-patients-ministry-of-ayush/</link>
					<comments>https://news.jugaadin.com/ayush-64-can-be-recommended-for-asymptomatic-mild-to-moderate-covid-19-patients-ministry-of-ayush/#respond</comments>
		
		<dc:creator><![CDATA[Seema Jain]]></dc:creator>
		<pubDate>Thu, 29 Apr 2021 09:19:18 +0000</pubDate>
				<category><![CDATA[Lifestyle]]></category>
		<category><![CDATA[Anti malarial drug]]></category>
		<category><![CDATA[Ayush 64]]></category>
		<category><![CDATA[Ayush 64 for Covid patients]]></category>
		<category><![CDATA[Ayush 64 Ingredients]]></category>
		<category><![CDATA[COVID 19]]></category>
		<category><![CDATA[ministry of AYUSH]]></category>
		<guid isPermaLink="false">http://news.jugaadin.com/?p=24125</guid>

					<description><![CDATA[<p>Amid India’s fight against the second wave of COVID 19, the Ministry of Ayush has brought Ayush 64 as a ray of hope for COVID patients having mild to moderate symptoms. The Ministry of Ayush-Council of Scientific and Industrial Research (CSIR) collaboration has recently completed a robust multi-centre clinical trial to evaluate the safety and [&#8230;]</p>
The post <a href="https://news.jugaadin.com/ayush-64-can-be-recommended-for-asymptomatic-mild-to-moderate-covid-19-patients-ministry-of-ayush/">AYUSH 64 can be recommended for asymptomatic, mild to moderate COVID-19 patients: Ministry of Ayush</a> first appeared on <a href="https://news.jugaadin.com">Jugaadin News  </a>.]]></description>
										<content:encoded><![CDATA[<p class="has-medium-font-size">Amid India’s fight against the second wave of COVID 19, the Ministry of Ayush has brought Ayush 64 as a ray of hope for COVID patients having mild to moderate symptoms.</p>



<p class="has-medium-font-size">The Ministry of Ayush-Council of Scientific and Industrial Research (CSIR) collaboration has recently completed a robust multi-centre clinical trial to evaluate the safety and efficacy of AYUSH 64 in the management of mild to moderate COVID-19 patients.</p>



<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"><div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="474" data-dnt="true"><p lang="en" dir="ltr">LIVE Now<br><br>Press briefing on <a href="https://twitter.com/moayush?ref_src=twsrc%5Etfw">@moayush</a> response to the <a href="https://twitter.com/hashtag/COVID19?src=hash&amp;ref_src=twsrc%5Etfw">#COVID19</a> pandemic, through VC<br><br>Watch on <a href="https://twitter.com/hashtag/PIB?src=hash&amp;ref_src=twsrc%5Etfw">#PIB</a>&#39;s<br>YouTube: <a href="https://t.co/zIQQ5ZYz9E">https://t.co/zIQQ5ZYz9E</a></p>&mdash; PIB India (@PIB_India) <a href="https://twitter.com/PIB_India/status/1387657903218171907?ref_src=twsrc%5Etfw">April 29, 2021</a></blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>
</div></figure>



<p class="has-medium-font-size">In the research, it is found that Ayush 64, a polyherbal formulation is useful in the treatment of asymptomatic, mild, and moderate COVID-19 infection as an adjunct to standard care. Initially, the drug was developed for Malaria in the year 1980 and now is repurposed for COVID-19 by Central Council for Research in Ayurvedic Sciences (CCRAS), Ministry of Ayush.</p>



<p class="has-medium-font-size">Dr Arvind Chopra, Director, Centre for Rheumatic Diseases, Pune and honorary chief clinical coordinator of the Ministry of Ayush &#8211; CSIR collaboration informed that the trial was conducted at three centres. KGMU, Lucknow; DMIMS, Wardha and BMC COVID Centre, Mumbai involving 70 participants in each arm. Dr Chopra stated that AYUSH 64 as an adjunct to standard of care (SoC) showed significant improvement and thus lesser period of hospitalization as compared SoC alone.</p>



<p class="has-medium-font-size">Dr. Bhushan Patwardhan, National Research Professor, another researcher stated that the AYUSH-64 study is highly encouraging and in the current crisis situations needy patients should be able to get benefits of Ayush 64. </p>



<p class="has-medium-font-size">Dr. N. Srikanth, Director General, CCRAS elaborated that the outcome of the seven clinical studies has revealed that AYUSH 64 exhibits early clinical recovery in COVID-19 cases, and additional studies on Ayush 64 are underway at reputed research institutes including CSIR-IIIM, DBT-THSTI, ICMR-NIN, AIIMS Jodhpur and Medical Colleges including Post Graduate Institute of Medical Education &amp; Research, Chandigarh; King George&#8217;s Medical University, Lucknow; Government Medical College, Nagpur; Datta Meghe Institute of Medical Sciences, Nagpur.</p>



<p class="has-large-font-size"><strong>What are Ayush 64 Ingredients?</strong></p>



<p class="has-medium-font-size">AYUSH 64 comprises <strong><em>Alstonia scholaris</em> </strong>(aqueous bark extract), <em><strong>Picrorhiza kurroa</strong></em> (aqueous rhizome extract), <em><strong>Swertia chirata</strong></em> (aqueous extract of the whole plant), and <strong><em>Caesalpinia crista</em></strong> (fine-powdered seed pulp). It is an extensively studied scientifically developed, safe, and effective Ayurveda formulation. </p>The post <a href="https://news.jugaadin.com/ayush-64-can-be-recommended-for-asymptomatic-mild-to-moderate-covid-19-patients-ministry-of-ayush/">AYUSH 64 can be recommended for asymptomatic, mild to moderate COVID-19 patients: Ministry of Ayush</a> first appeared on <a href="https://news.jugaadin.com">Jugaadin News  </a>.]]></content:encoded>
					
					<wfw:commentRss>https://news.jugaadin.com/ayush-64-can-be-recommended-for-asymptomatic-mild-to-moderate-covid-19-patients-ministry-of-ayush/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">24125</post-id>	</item>
	</channel>
</rss>
